Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.

Hakkaart C, Pearson JF, Marquart L, Dennis J, Wiggins GAR, Barnes DR, Robinson BA, Mace PD, Aittomäki K, Andrulis IL, Arun BK, Azzollini J, Balmaña J, Barkardottir RB, Belhadj S, Berger L, Blok MJ, Boonen SE, Borde J, Bradbury AR, Brunet J, Buys SS, Caligo MA, Campbell I, Chung WK, Claes KBM, GEMO Study Collaborators, EMBRACE Collaborators, Collonge-Rame MA, Cook J, Cosgrove C, Couch FJ, Daly MB, Dandiker S, Davidson R, de la Hoya M, de Putter R, Delnatte C, Dhawan M, Diez O, Ding YC, Domchek SM, Donaldson A, Eason J, Easton DF, Ehrencrona H, Engel C, Evans DG, Faust U, Feliubadaló L, Fostira F, Friedman E, Frone M, Frost D, Garber J, Gayther SA, Gehrig A, Gesta P, Godwin AK, Goldgar DE, Greene MH, Hahnen E, Hake CR, Hamann U, Hansen TVO, Hauke J, Hentschel J, Herold N, Honisch E, Hulick PJ, Imyanitov EN, SWE-BRCA Investigators, kConFab Investigators, HEBON Investigators, Isaacs C, Izatt L, Izquierdo A, Jakubowska A, James PA, Janavicius R, John EM, Joseph V, Karlan BY, Kemp Z, Kirk J, Konstantopoulou I, Koudijs M, Kwong A, Laitman Y, Lalloo F, Lasset C, Lautrup C, Lazaro C, Legrand C, Leslie G, Lesueur F, Mai PL, Manoukian S, Mari V, Martens JWM, McGuffog L, Mebirouk N, Meindl A, Miller A, Montagna M, Moserle L, Mouret-Fourme E, Musgrave H, Nambot S, Nathanson KL, Neuhausen SL, Nevanlinna H, Yie JNY, Nguyen-Dumont T, Nikitina-Zake L, Offit K, Olah E, Olopade OI, Osorio A, Ott CE, Park SK, Parsons MT, Pedersen IS, Peixoto A, Perez-Segura P, Peterlongo P, Pocza T, Radice P, Ramser J, Rantala J, Rodriguez GC, Rønlund K, Rosenberg EH, Rossing M, Schmutzler RK, Shah PD, Sharif S, Sharma P, Side LE, Simard J, Singer CF, Snape K, Steinemann D, Stoppa-Lyonnet D, Sutter C, Tan YY, Teixeira MR, Teo SH, Thomassen M, Thull DL, Tischkowitz M, Toland AE, Trainer AH, Tripathi V, Tung N, van Engelen K, van Rensburg EJ, Vega A, Viel A, Walker L, Weitzel JN, Wevers MR, Chenevix-Trench G, Spurdle AB, Antoniou AC, Walker LC

Open source

DOI
10.1038/s42003-022-03978-6
Published
2022 Oct 6
Container
Communications biology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s42003-022-03978-6,
  title = {Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.},
  author = {Hakkaart C and Pearson JF and Marquart L and Dennis J and Wiggins GAR and Barnes DR and Robinson BA and Mace PD and Aittomäki K and Andrulis IL and Arun BK and Azzollini J and Balmaña J and Barkardottir RB and Belhadj S and Berger L and Blok MJ and Boonen SE and Borde J and Bradbury AR and Brunet J and Buys SS and Caligo MA and Campbell I and Chung WK and Claes KBM and GEMO Study Collaborators and EMBRACE Collaborators and Collonge-Rame MA and Cook J and Cosgrove C and Couch FJ and Daly MB and Dandiker S and Davidson R and de la Hoya M and de Putter R and Delnatte C and Dhawan M and Diez O and Ding YC and Domchek SM and Donaldson A and Eason J and Easton DF and Ehrencrona H and Engel C and Evans DG and Faust U and Feliubadaló L and Fostira F and Friedman E and Frone M and Frost D and Garber J and Gayther SA and Gehrig A and Gesta P and Godwin AK and Goldgar DE and Greene MH and Hahnen E and Hake CR and Hamann U and Hansen TVO and Hauke J and Hentschel J and Herold N and Honisch E and Hulick PJ and Imyanitov EN and SWE-BRCA Investigators and kConFab Investigators and HEBON Investigators and Isaacs C and Izatt L and Izquierdo A and Jakubowska A and James PA and Janavicius R and John EM and Joseph V and Karlan BY and Kemp Z and Kirk J and Konstantopoulou I and Koudijs M and Kwong A and Laitman Y and Lalloo F and Lasset C and Lautrup C and Lazaro C and Legrand C and Leslie G and Lesueur F and Mai PL and Manoukian S and Mari V and Martens JWM and McGuffog L and Mebirouk N and Meindl A and Miller A and Montagna M and Moserle L and Mouret-Fourme E and Musgrave H and Nambot S and Nathanson KL and Neuhausen SL and Nevanlinna H and Yie JNY and Nguyen-Dumont T and Nikitina-Zake L and Offit K and Olah E and Olopade OI and Osorio A and Ott CE and Park SK and Parsons MT and Pedersen IS and Peixoto A and Perez-Segura P and Peterlongo P and Pocza T and Radice P and Ramser J and Rantala J and Rodriguez GC and Rønlund K and Rosenberg EH and Rossing M and Schmutzler RK and Shah PD and Sharif S and Sharma P and Side LE and Simard J and Singer CF and Snape K and Steinemann D and Stoppa-Lyonnet D and Sutter C and Tan YY and Teixeira MR and Teo SH and Thomassen M and Thull DL and Tischkowitz M and Toland AE and Trainer AH and Tripathi V and Tung N and van Engelen K and van Rensburg EJ and Vega A and Viel A and Walker L and Weitzel JN and Wevers MR and Chenevix-Trench G and Spurdle AB and Antoniou AC and Walker LC},
  year = {2022},
  journal = {Communications biology},
  doi = {10.1038/s42003-022-03978-6},
  url = {https://doi.org/10.1038/s42003-022-03978-6}
}

RIS

TY  - JOUR
TI  - Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
AU  - Hakkaart C
AU  - Pearson JF
AU  - Marquart L
AU  - Dennis J
AU  - Wiggins GAR
AU  - Barnes DR
AU  - Robinson BA
AU  - Mace PD
AU  - Aittomäki K
AU  - Andrulis IL
AU  - Arun BK
AU  - Azzollini J
AU  - Balmaña J
AU  - Barkardottir RB
AU  - Belhadj S
AU  - Berger L
AU  - Blok MJ
AU  - Boonen SE
AU  - Borde J
AU  - Bradbury AR
AU  - Brunet J
AU  - Buys SS
AU  - Caligo MA
AU  - Campbell I
AU  - Chung WK
AU  - Claes KBM
AU  - GEMO Study Collaborators
AU  - EMBRACE Collaborators
AU  - Collonge-Rame MA
AU  - Cook J
AU  - Cosgrove C
AU  - Couch FJ
AU  - Daly MB
AU  - Dandiker S
AU  - Davidson R
AU  - de la Hoya M
AU  - de Putter R
AU  - Delnatte C
AU  - Dhawan M
AU  - Diez O
AU  - Ding YC
AU  - Domchek SM
AU  - Donaldson A
AU  - Eason J
AU  - Easton DF
AU  - Ehrencrona H
AU  - Engel C
AU  - Evans DG
AU  - Faust U
AU  - Feliubadaló L
AU  - Fostira F
AU  - Friedman E
AU  - Frone M
AU  - Frost D
AU  - Garber J
AU  - Gayther SA
AU  - Gehrig A
AU  - Gesta P
AU  - Godwin AK
AU  - Goldgar DE
AU  - Greene MH
AU  - Hahnen E
AU  - Hake CR
AU  - Hamann U
AU  - Hansen TVO
AU  - Hauke J
AU  - Hentschel J
AU  - Herold N
AU  - Honisch E
AU  - Hulick PJ
AU  - Imyanitov EN
AU  - SWE-BRCA Investigators
AU  - kConFab Investigators
AU  - HEBON Investigators
AU  - Isaacs C
AU  - Izatt L
AU  - Izquierdo A
AU  - Jakubowska A
AU  - James PA
AU  - Janavicius R
AU  - John EM
AU  - Joseph V
AU  - Karlan BY
AU  - Kemp Z
AU  - Kirk J
AU  - Konstantopoulou I
AU  - Koudijs M
AU  - Kwong A
AU  - Laitman Y
AU  - Lalloo F
AU  - Lasset C
AU  - Lautrup C
AU  - Lazaro C
AU  - Legrand C
AU  - Leslie G
AU  - Lesueur F
AU  - Mai PL
AU  - Manoukian S
AU  - Mari V
AU  - Martens JWM
AU  - McGuffog L
AU  - Mebirouk N
AU  - Meindl A
AU  - Miller A
AU  - Montagna M
AU  - Moserle L
AU  - Mouret-Fourme E
AU  - Musgrave H
AU  - Nambot S
AU  - Nathanson KL
AU  - Neuhausen SL
AU  - Nevanlinna H
AU  - Yie JNY
AU  - Nguyen-Dumont T
AU  - Nikitina-Zake L
AU  - Offit K
AU  - Olah E
AU  - Olopade OI
AU  - Osorio A
AU  - Ott CE
AU  - Park SK
AU  - Parsons MT
AU  - Pedersen IS
AU  - Peixoto A
AU  - Perez-Segura P
AU  - Peterlongo P
AU  - Pocza T
AU  - Radice P
AU  - Ramser J
AU  - Rantala J
AU  - Rodriguez GC
AU  - Rønlund K
AU  - Rosenberg EH
AU  - Rossing M
AU  - Schmutzler RK
AU  - Shah PD
AU  - Sharif S
AU  - Sharma P
AU  - Side LE
AU  - Simard J
AU  - Singer CF
AU  - Snape K
AU  - Steinemann D
AU  - Stoppa-Lyonnet D
AU  - Sutter C
AU  - Tan YY
AU  - Teixeira MR
AU  - Teo SH
AU  - Thomassen M
AU  - Thull DL
AU  - Tischkowitz M
AU  - Toland AE
AU  - Trainer AH
AU  - Tripathi V
AU  - Tung N
AU  - van Engelen K
AU  - van Rensburg EJ
AU  - Vega A
AU  - Viel A
AU  - Walker L
AU  - Weitzel JN
AU  - Wevers MR
AU  - Chenevix-Trench G
AU  - Spurdle AB
AU  - Antoniou AC
AU  - Walker LC
PY  - 2022
JO  - Communications biology
DO  - 10.1038/s42003-022-03978-6
UR  - https://doi.org/10.1038/s42003-022-03978-6
ER  -

APA

C, H., JF, P., L, M., J, D., GAR, W., DR, B., BA, R., PD, M., K, A., IL, A., BK, A., J, A., J, B., RB, B., S, B., L, B., MJ, B., SE, B., J, B., AR, B., J, B., SS, B., MA, C., I, C., WK, C., KBM, C., Collaborators, G. S., Collaborators, E., MA, C., J, C., C, C., FJ, C., MB, D., S, D., R, D., M, D. L. H., R, D. P., C, D., M, D., O, D., YC, D., SM, D., A, D., J, E., DF, E., H, E., C, E., DG, E., U, F., L, F., F, F., E, F., M, F., D, F., J, G., SA, G., A, G., P, G., AK, G., DE, G., MH, G., E, H., CR, H., U, H., TVO, H., J, H., J, H., N, H., E, H., PJ, H., EN, I., Investigators, S., Investigators, K., Investigators, H., C, I., L, I., A, I., A, J., PA, J., R, J., EM, J., V, J., BY, K., Z, K., J, K., I, K., M, K., A, K., Y, L., F, L., C, L., C, L., C, L., C, L., G, L., F, L., PL, M., S, M., V, M., JWM, M., L, M., N, M., A, M., A, M., M, M., L, M., E, M., H, M., S, N., KL, N., SL, N., H, N., JNY, Y., T, N., L, N., K, O., E, O., OI, O., A, O., CE, O., SK, P., MT, P., IS, P., A, P., P, P., P, P., T, P., P, R., J, R., J, R., GC, R., K, R., EH, R., M, R., RK, S., PD, S., S, S., P, S., LE, S., J, S., CF, S., K, S., D, S., D, S., C, S., YY, T., MR, T., SH, T., M, T., DL, T., M, T., AE, T., AH, T., V, T., N, T., K, V. E., EJ, V. R., A, V., A, V., L, W., JN, W., MR, W., G, C., AB, S., AC, A., & LC, W. (2022). Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.. Communications biology. https://doi.org/10.1038/s42003-022-03978-6

Source records